The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where Sylvain Rheims sits on this spectrum.
This scientist: 200 publications — 62nd percentile
62% of scientists in this discipline score the same or lower.
The last bar groups every scientist with 887 publications or more.
The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where Sylvain Rheims sits on this spectrum.
This scientist: 52 D-Index — 46th percentile
46% of scientists in this discipline score the same or lower.
The last bar groups every scientist with 163 D-Index or more.
Sylvain Rheims is affiliated with Claude Bernard University Lyon 1 in France and has contributed extensively to the fields of Medicine and Neuroscience. Their research portfolio includes a significant focus on Cognitive Neuroscience, Psychiatry and Mental Health, Pediatrics, Perinatology and Child Health, Cellular and Molecular Neuroscience, and Neurology.
The main areas of study addressed in Rheims' work involve Epilepsy research and treatment, Neuroscience and Neuropharmacology Research, EEG and Brain-Computer Interfaces, Pharmacological Effects and Toxicity Studies, Functional Brain Connectivity Studies, Neural dynamics and brain function, and Neuroscience of respiration and sleep.
Frequently publishing in scientific journals, Rheims has multiple papers in these venues:
Some of Rheims' recent significant papers include:
Collaborations with other researchers form a notable part of Rheims' scholarly activity. Frequent co-authors include Philippe Ryvlin, Hélène Catenoix, Philippe Kahane, Fabricē Bartolomei, and Marc Guénot, with multiple joint publications reflecting their interconnected research efforts.
Rheims' work displays a strong interdisciplinary approach, combining various subfields of neuroscience and medicine to address complex neurological disorders, particularly epilepsy. This comprehensive focus encompasses both clinical and basic science perspectives, analyzing neural mechanisms and treatment outcomes.
Philippe Ryvlin;Lina Nashef;Samden D Lhatoo;Lisa M Bateman
Rimante Minkeviciene;Sylvain Rheims;Marton B Dobszay;Misha Zilberter
Philippe Ryvlin;Philippe Ryvlin;Philippe Ryvlin;J Helen Cross;Sylvain Rheims;Sylvain Rheims
Philippe Ryvlin;Michel Cucherat;Sylvain Rheims
Herm J Lamberink;Willem M Otte;Ingmar Blümcke;Kees P J Braun
Philippe Ryvlin;Lorella Minotti;Geneviève Demarquay;Edouard Hirsch
Philippe Ryvlin;Sylvain Rheims;Lawrence J Hirsch;Arseny Sokolov
Carmen Barba;Sylvain Rheims;Sylvain Rheims;Lorella Minotti;Marc Guénot
Sylvain Rheims;Emilio Perucca;Michel Cucherat;Philippe Ryvlin
Sylvain Rheims;Sylvain Rheims;Michel Cucherat;Alexis Arzimanoglou;Philippe Ryvlin;Philippe Ryvlin
Pierre Bourdillon;Jean Isnard;Hélène Catenoix;Alexandra Montavont
Sylvain Rheims;Philippe Ryvlin;Philippe Ryvlin;Clarisse Scherer;Lorella Minotti
Maxime Olivier Baud;Thomas Perneger;Attila Rácz;Max C. Pensel
Philippe Domenech;Philippe Domenech;Philippe Domenech;Sylvain Rheims;Sylvain Rheims;Etienne Koechlin;Etienne Koechlin;Etienne Koechlin
Lena Trebaul;Pierre Deman;Viateur Tuyisenge;Maciej Jedynak
Sylvain Rheims;Marat Minlebaev;Anton Ivanov;Alfonso Represa
Roman Tyzio;Marat Minlebaev;Sylvain Rheims;Anton Ivanov
Florian Chouchou;François Mauguière;Ophélie Vallayer;Hélène Catenoix
Deborah Guery;Sylvain Rheims
Veriano Alexandre;Blanca Mercedes;Luc Valton;Louis Maillard
Sylvain Rheims;Carl D. Holmgren;Genevieve Chazal;Jan Mulder
Philippe Ryvlin;Sylvain Rheims;Gail Risse
Sezgi Goksan;Caroline Hartley;Faith Emery;Naomi Cockrill
If you think any of the details on this page are incorrect, let us know.
University of Cambridge
Paul Scherrer Institute
University of Haifa
University of Nottingham
Yale University
University of Nebraska Medical Center
University of Southern California
Emory University
Harvard University
Spanish National Research Council
University of California, San Diego
University of Wollongong
University of Zurich
Centre national de la recherche scientifique, CNRS
University of Exeter
US Food and Drug Administration
